The Effect of Nebivolol on Endothelial Dysfunction in African Americans

Status Completed

Clinical Trial Summary

High blood pressure (hypertension) is called the "silent killer" because many people do not know they have it, and do not know when it is well controlled. Unfortunately, over time uncontrolled hypertension can cause irreversible organ damage that can lead to heart attack, stroke, heart failure, and kidney failure. If a person cannot control their blood pressure with diet and exercise, doctors often prescribe medications to help control the blood pressure. Nebivolol is a medication that has been recently approved by the FDA for the treatment of hypertension. Our study will investigate whether treatment with nebivolol, as compared to another medication called metoprolol, in African Americans with hypertension will be more effective in protecting blood vessels against the harmful effects of high blood pressure.

Over time high blood pressure causes hardening of the arteries (atherosclerosis) which leads to narrowing of the blood vessels and reduces blood flow to our organs. Arteries also relax and contract naturally, which further changes the blood supply. When arteries are narrowed, exercise can bring on a condition in which the blood supply is inadequate, and this might result in the sensation of pain.

Cells lining our blood vessels produce a variety of substances that normally cause arteries to relax. Two of these substances are called nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF). We are trying to determine the nature of these substances in African Americans with high blood pressure and how it is affected by nebivolol and metoprolol. One way to determine this is to inject drugs such as L-NMMA (N(G)-monomethyl-L-arginine) or TEA (tetraethylammonium chloride), which block the production of NO and EDHF respectively, and then study what happens to the blood flow at rest and during exercise. It is our thought that nebivolol, in comparison to metoprolol, will increase the substances that naturally cause arteries to relax and improve blood supply.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01049009
Study type	Interventional
Source	Emory University
Contact
Status	Completed
Phase	Phase 4
Start date	December 2009
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03812614` - Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support	N/A
Completed	`NCT03650166` - High BP and Home Monitoring Experience (HoME) Study	N/A
Recruiting	`NCT02908139` - Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients	N/A
Completed	`NCT01622400` - Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk	N/A
Completed	`NCT00659672` - Effect of Whey Protein on Blood Pressure	N/A
Completed	`NCT00473681` - Intervention Study to Control High Blood Pressure for Korean American	N/A
Completed	`NCT03542240` - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome	N/A
Active, not recruiting	`NCT05526092` - OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals	N/A
Completed	`NCT02218931` - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes	N/A
Recruiting	`NCT03753204` - Salt-Sensitivity and Immunity Cell Activation	Phase 1/Phase 2
Not yet recruiting	`NCT04064281` - The Healthy Cantonese Diet on Cardiometabolic Syndrome	N/A
Completed	`NCT04479384` - The Immediate Effect of an Osteopathic Manual Treatment on Blood Pressure in Adults With Hypertension - a Pilot Study.	N/A
Completed	`NCT04082819` - MediBeat - HeartBeat Observation Trial	N/A
Completed	`NCT03555344` - Effect of Mantra on Hypertensive Patients	N/A
Withdrawn	`NCT03319823` - Treating Nocturnal Hypertension and Nocturia in African American Men	Phase 4
Completed	`NCT00689819` - Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients	N/A
Completed	`NCT00417170` - Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome	Phase 2
Completed	`NCT00130156` - Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension	Phase 4
Completed	`NCT05808556` - Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure	N/A
Recruiting	`NCT05321368` - A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms